期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

多靶点药物的开发策略及研究进展 被引量：4

Progress in Research of Multi-target drugs and Their Development Strategy
在线阅读 下载PDF
导出
摘要 多靶点药物治疗肿瘤、抑郁症、糖尿病等复杂性疾病效果显著,越来越受到重视。本文综述了多靶点药物的分类、发现策略和优势,总结和展望了多靶点药物在复杂性疾病中的应用现状及前景。 Multi-target drugs get more attention for their significant therapeutic effect of some complex diseases such as cancer, depression and diabetes. The review summarized the classification, discovery strategies and advantages. Current situation and expected future prospects of multi-targets drugs for complex disease therapy would be summarized, too.
作者 钱文麒 韩伟 唐三植 陆涛
机构地区 中国药科大学理学院
出处 《广东化工》 CAS 2014年第8期69-72,共4页 Guangdong Chemical Industry
关键词 多靶点药物 发现策略 优势 复杂性疾病 multi-target drugs： development strategies： advantages complex disease
分类号 TQ [化学工程]
  • 相关文献

参考文献18

  • 1Rothman R B,Baumann M H,Savage J E,et al.Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.Circulation,2000,102(23):2836-2841.
  • 2Hopkins A L.Network pharmacology:the next paradigm in drug discovery.Nat Chem Biol,2008,4(11):682-690.
  • 3Zimmermann GR,Lehar J,Keith CT.Multi-target therapeutics:when the whole is greater than the sum of the parts[J].Drug Discov Today,2007,12:34-42.
  • 4Petrelli A,G iordano S.From sing le-to multi-target drugs in cancer therapy:when a spec-ificity becomes an advantage[J].CurrMed Chem,2008,15(5):422-432.
  • 5Morphy R,Rankovic Z.Designing multiple ligands-medicinal chem istry strategies and challenges[J].CurrPharm Des,2009,15(6):587-6001.
  • 6Morphy R.Selective Multitargeted Drugs.In Polypharmacology in Drug Discovery:Peters,J-U,Ed; Wiley:Hoboken,2012:247-262.
  • 7Atkinson P J,Bromidge S M,Duxon M S,et al.3,4-Dihydro-2H-benzoxazinones are 5-HT1A receptor antagonists with potent 5-HT reuptake inhibitory activity.Bioorg Med Chem Lett,2005,15(3):737-741.
  • 8Silver L L.Polypharmacology as an Emerging Trend in Antibacterial Discovery.In Polypharmacology in Drug Discovery; Peters,J-U,Ed; Wiley:Hoboken,2012:167-202.
  • 9Petrelli A.Polypharmacological Kinase Inhibitors:New Hopes for Cancer Therapy.In Polypharmacology in Drug Discovery; Peters,J U,Ed,Wiley:Hoboken,2012:149-165.
  • 10Azmi A S.Network pharmacology for cancer drug discovery:are we there yet? Future Med Chem,2012,4(8):939-941.

二级参考文献30

共引文献20

同被引文献43

  • 1Maconi G,Magro F.Comparing techniques to achieve high accuracy and low cost:how should we first diagnose Crohn's disease?[J].J Comp Eff Res,2015,4(2):75-78.
  • 2van de Veerdonk FL,Netea MG,van der Meer JW.Case39-2014:A girl with Crohn's disease and pulmonary nodules[J].N Engl J Med,2015,372(13):1272-1273.
  • 3Monteleone G,Neurath MF,Ardizzone S,et al.Mongersen,an oral SMAD7 antisense oligonucleotide,and Crohn's disease[J].N Engl J Med,2015,372(12):1104-1113.
  • 4Karczewski J,Poniedzialek B,Piotr R,et al.Different effect of smoking on genders in Crohn's disease[J].Turk J Gastroenterol,2015,26(2):133-139.
  • 5Fitzmorris PS,Colantonio LD,Torrazza Perez E,et al.Impact of metabolic syndrome on the hospitalization rate of Crohn's disease patients seen at a tertiary care center:a retrospective cohort study[J].Digestion,2015,91(3):257-262.
  • 6Lepor NE,Contreras L,Desai C,et al.Correction to"The Potential Role of Anti-PCSK9 Monoclonal Antibodies in the Management of Hypercholesterolemia"[J].Rev Cardiovasc Med,2015,16(1):94-309.
  • 7Rahimi R,Ebtekar M,Moazzeni SM,et al.Optimization of multi-epitopic HIV-1 recombinant protein expression in prokaryote system and conjugation to mouse DEC-205monoclonal antibody:implication for in-vivo targeted delivery of dendritic cells[J].Iran J Basic Med Sci,2015,18(2):145-152.
  • 8Jordan N,Lutalo PM,D'Cruz DP.Progress with the use of monoclonal antibodies for the treatment of systemic lupus erythematosus[J].Immunotherapy,2015,7(3):255-270.
  • 9Ezzatifar F,Majidi J,Baradaran B,et al.Large scale generation and characterization of anti-human Ig A monoclonal antibody in ascitic fluid of BALB/c mice[J].Adv Pharm Bull,2015,5(1):97-102.
  • 10Kouiavskaia D,Chen Z,Dragunsky E,et al.A single chimpanzee-human neutralizing monoclonal antibody provides post-exposure protection against type 1 and type 2 polioviruses[J].J Clin Virol,2015,65:32-37.

引证文献4

二级引证文献22

广东化工
2014年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部